Relationship between Apparent Diffusion Coefficient Distribution and Cancer Grade in Prostate Cancer and Benign Prostatic Hyperplasia

被引:9
作者
Saito, Shigeyoshi [1 ,2 ]
Koyama, Yoshihiro [3 ]
Ueda, Junpei [1 ]
Hashido, Takashi [3 ]
机构
[1] Osaka Univ, Grad Sch Med, Div Hlth Sci, Dept Med Phys & Engn, Osaka 5650871, Japan
[2] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Adv Med Technol, Osaka 5650871, Japan
[3] Osaka Univ Hosp, Dept Med Technol, Div Radiol, Osaka 5648565, Japan
基金
日本学术振兴会;
关键词
histogram-derived ADC parameters; stromal hyperplasia; glandular hyperplasia; prostate cancer; benign prostate hyperplasia; CONTRAST-ENHANCED MRI; LOCAL TREATMENT; GLEASON SCORE; NORMAL TISSUE; GUIDELINES; DIAGNOSIS; DIFFERENTIATION; CELLULARITY; UPDATE; BIOPSY;
D O I
10.3390/diagnostics12020525
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this paper was to assess the associations between prostate cancer aggressiveness and histogram-derived apparent diffusion coefficient (ADC) parameters and determine which ADC parameters may help distinguish among stromal hyperplasia (SH), glandular hyperplasia (GH), and low-grade, intermediate-grade, and high-grade prostate cancers. The mean, median, minimum, maximum, and 10th and 25th percentile ADC values were determined from the ADC histogram and compared among two benign prostate hyperplasia (BPH) groups and three Gleason score (GS) groups. Seventy lesions were identified in 58 patients who had undergone proctectomy. Thirty-nine lesions were prostate cancers (GS 6 = 7 lesions, GS 7 = 19 lesions, GS 8 = 11 lesions, GS 9 = 2 lesions), and thirty-one lesions were BPH (SH = 15 lesions, GH = 16 lesions). There were statistically significant differences in 10th percentile and 25th percentile ADC values when comparing GS 6 to GS 7 (p < 0.05). The 10th percentile ADC values yielded the highest area under the curve (AUC). Tenth and 25th percentile ADCs can be used to more accurately differentiate lesions with GS 6 from those with GS 7 than other ADC parameters. Our data indicate that the major challenge with ADC mapping is to differentiate between SH and GS 6, and SH and GS 7.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Men’s theories about benign prostatic hyperplasia and prostate cancer following a benign prostatic hyperplasia decision aid
    Margaret Holmes-Rovner
    Chrystal Price
    David R. Rovner
    Karen Kelly-Blake
    Janet Lillie
    Celia Wills
    Vence L. Bonham
    Journal of General Internal Medicine, 2006, 21 : 56 - 60
  • [42] Apparent Diffusion Coefficient for Prostate Cancer Imaging: Impact of b Values
    Peng, Yahui
    Jiang, Yulei
    Antic, Tatjana
    Sethi, Ila
    Schmid-Tannwald, Christine
    Eggener, Scott
    Oto, Aytekin
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2014, 202 (03) : W247 - W253
  • [43] Ki67 and the apparent diffusion coefficient in postoperative prostate cancer with endocrine therapy
    He, Jun
    Che, Bangwei
    Li, Po
    Li, Wei
    Huang, Tao
    Chen, Peng
    Liu, Miao
    Li, Guangyu
    Zhong, Siwen
    Tang, Kaifa
    FRONTIERS IN SURGERY, 2023, 10
  • [44] Estrogen receptors in the human male prostatic urethra and prostate in prostatic cancer and benign prostatic hyperplasia
    Bodker, A
    Bruun, J
    Balslev, E
    Iversen, HG
    Meyhoff, HH
    Andersson, KE
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1999, 33 (04): : 237 - 242
  • [45] Diffusion-Weighted Imaging of Prostate Cancer: Correlation Between Apparent Diffusion Coefficient Values and Tumor Proliferation
    Wang, Xi Zhen
    Wang, Bin
    Gao, Zhi Qin
    Liu, Jin Gang
    Liu, Zuo Qin
    Niu, Qing Liang
    Sun, Zhen Kui
    Yuan, Yu Xiao
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2009, 29 (06) : 1360 - 1366
  • [46] Evaluation of Apparent Diffusion Coefficient as a Predictor of Grade Reclassification in Men on Active Surveillance for Prostate Cancer
    Huang, Mitchell M.
    Macura, Katarzyna J.
    Landis, Patricia
    Epstein, Jonathan, I
    Gawande, Rakhee
    Carter, H. Ballentine
    Mamawala, Mufaddal
    UROLOGY, 2020, 138 : 84 - 90
  • [47] Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk
    S-C Hung
    S-W Lai
    P-Y Tsai
    P-C Chen
    H-C Wu
    W-H Lin
    F-C Sung
    British Journal of Cancer, 2013, 108 : 1778 - 1783
  • [48] Diffusion-Tensor MRI at 3 T: Differentiation of Central Gland Prostate Cancer From Benign Prostatic Hyperplasia
    Park, Sung Yoon
    Kim, Chan Kyo
    Park, Byung Kwan
    Ha, Sang Yun
    Kwon, Ghee Young
    Kim, Bohyun
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2014, 202 (03) : W254 - W262
  • [49] Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia
    Matos, A. R.
    Coutinho-Camillo, C. M.
    Thuler, L. C. S.
    Fonseca, F. P.
    Soares, F. A.
    Silva, E. A.
    Gimba, E. R.
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2013, 94 (03) : 438 - 444
  • [50] Benign prostatic hyperplasia and prostate cancer: an overview for primary care physicians
    Sausville, J.
    Naslund, M.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (13) : 1740 - 1745